SGMO sangamo.com Revenue Growth QoQ

Corporate emblem and logo of Sangamo (SGMO)

Sangamo Therapeutics (SGMO) operates a business that is independent of economic fluctuations, as demand for the treatment of genetic pathologies remains stable. The relative change in quarterly revenue confirms this trend, with the 87.80 metric serving as the target level. Revenues currently rely on partner payments while testing continues. Patents for the ZFP platform provide the company with significant pricing power.

SGMO (Sangamo) Quarterly Revenue Growth history from 07/04/2022 to 05/09/2026

Analytical breakdowns and data insights for company Sangamo (SGMO)

Analysis of all company metrics:Sangamo - SGMO
Manufactured products of Sangamo Therapeutics Inc.

Quarterly revenue growth for Sangamo Therapeutics on the GURU.Markets platform reflects the effectiveness of the company's patent portfolio commercialization. This indicator measures the percentage change in sales volume between the current and previous quarters, capturing the speed of business scaling. The calculation model compares current receipts with historical data, identifying the impact of licensing agreements with pharma behemoths on cash flow. Stable dynamics confirm the fundamental resilience of the monetization model for scientific discoveries.

Who Sangamo Therapeutics competes with

TEM - Revenue Growth QoQ|Quarterly Sales Growth Rate qiagen.com QGEN|IONS: Quarterly Revenue Growth|Repligen Corp - Quarterly Revenue Increase|RNA (Avidity Corp) - Quarterly Revenue Growth|CRISPR Therapeutics Corp - Revenue Dynamics QoQ|Revenue Growth QoQ genedx.com (WGS)|Quarterly Revenue Growth ultragenyx.com (RARE)|Quarterly Revenue Growth BEAM (Beam Therapeutics Inc)|Sarepta Therapeutics Inc (SRPT) - Quarterly Revenue Growth Rate|twistbioscience.com - Quarterly Revenue Growth|10x Genomics, Inc. - Sales Change QoQ|NTLA (Intellia Corp) - Quarterly Sales Growth|Quarterly Sales Growth stoketherapeutics.com|Quarterly Sales Growth BLFS|Quarterly Sales Growth Wave Life Sciences Corp (WVE)|Quarterly Revenue Growth MAZE|Quarterly Sales Growth Rate Sionna Therapeutics Inc|Revenue Growth QoQ Prime Medicine Corp PRME|tayshagtx.com (TSHA) - Quarterly Revenue Growth Rate|QURE - Revenue Growth QoQ|MeiraGTx Holdings (MGTX) - Quarterly Sales Growth|Regenxbio (RGNX) - Revenue Growth QoQ|SLDB - Quarterly Sales Growth Rate|OCGN (Ocugen Inc) - Quarterly Revenue Growth|Revenue Growth QoQ PACB|Revenue Growth QoQ Benitec (BNTC)|Design Therapeutics Inc - Sales Growth QoQ|Revenue Growth QoQ Rocket Pharma RCKT|Quarterly Revenue Growth 4DMT FDMT|LXEO - Revenue Growth QoQ|Quarterly Revenue Growth Rate Korro Bio Inc.|EDIT: Quarterly Revenue Growth|SLN - Quarterly Sales Growth Rate|PRQR (ProQR Therapeutics) - Quarterly Revenue Growth|codexis.com (CDXS) - Quarterly Sales Growth Rate|Quarterly Revenue Growth NAUT|Quarterly Sales Growth Metagenomi, Inc. MGX|Revenue Growth QoQ Precision BioSciences DTIL|Quarterly Revenue Increase GBIO|BOLD - Revenue Growth QoQ|Quarterly Sales Growth Rate Exicure Inc. XCUR|Imunon, Inc. (IMNN) - Revenue Growth QoQ|RXi Pharmaceuticals - Quarterly Revenue Increase|MBIO (Mustang Bio) - Quarterly Revenue Growth|Sales Growth QoQ RNAZ (transcodetherapeutics.com)|Revenue Growth QoQ Bionano (BNGO)|Applied DNA Sciences - Sales Growth QoQ|Quarterly Revenue Growth BLUE (bluebirdbio.com)|ImmunoPrecise Antibodies (IPA) - Quarterly Revenue Growth Rate|omegatherapeutics.com - Quarterly Revenue Growth|Revenue Change vs Previous Quarter Singular Genomics Systems Inc (OMIC)|RGLS: Quarterly Revenue Growth|Syros Pharmaceuticals, Inc (SYRS) - Quarterly Revenue Growth|TBIO (telesisbio.com) - Quarterly Revenue Growth|TCON: Quarterly Revenue Increase|Revenue Growth QoQ Unity Biotechnology, Inc (UBX)